First Trust Advisors LP Reduces Holdings in USANA Health Sciences, Inc. (USNA)

First Trust Advisors LP lowered its position in USANA Health Sciences, Inc. (NYSE:USNA) by 19.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,436 shares of the company’s stock after selling 4,102 shares during the quarter. First Trust Advisors LP owned approximately 0.07% of USANA Health Sciences worth $1,006,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of USNA. BNP Paribas Arbitrage SA lifted its position in USANA Health Sciences by 13.1% in the second quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock valued at $135,000 after purchasing an additional 245 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of USANA Health Sciences by 17.6% during the second quarter. Victory Capital Management Inc. now owns 2,490 shares of the company’s stock valued at $160,000 after acquiring an additional 373 shares in the last quarter. Creative Planning raised its holdings in shares of USANA Health Sciences by 528.0% during the second quarter. Creative Planning now owns 2,512 shares of the company’s stock valued at $161,000 after acquiring an additional 2,112 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of USANA Health Sciences during the second quarter valued at approximately $162,000. Finally, Hikari Power Ltd bought a new position in shares of USANA Health Sciences during the second quarter valued at approximately $221,000. 43.82% of the stock is owned by institutional investors and hedge funds.

A number of brokerages recently commented on USNA. BidaskClub downgraded USANA Health Sciences from a “hold” rating to a “sell” rating in a report on Thursday, November 2nd. Pivotal Research increased their price objective on USANA Health Sciences from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Wednesday, October 25th.

USANA Health Sciences, Inc. (USNA) traded up $0.95 on Thursday, reaching $71.75. The company’s stock had a trading volume of 95,800 shares, compared to its average volume of 126,826. The company has a market capitalization of $1,698.67, a P/E ratio of 18.73 and a beta of 1.08. USANA Health Sciences, Inc. has a twelve month low of $52.55 and a twelve month high of $72.80.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $1.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.11. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The business had revenue of $261.77 million during the quarter, compared to the consensus estimate of $259.52 million. During the same quarter in the prior year, the company earned $2.40 earnings per share. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. sell-side analysts anticipate that USANA Health Sciences, Inc. will post 3.7 EPS for the current fiscal year.

In related news, major shareholder Global Ltd Gull sold 45,216 shares of the stock in a transaction on Wednesday, November 22nd. The stock was sold at an average price of $66.44, for a total transaction of $3,004,151.04. Following the sale, the insider now directly owns 11,694,053 shares of the company’s stock, valued at $776,952,881.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Myron W. Wentz sold 7,895 shares of the stock in a transaction on Friday, November 17th. The shares were sold at an average price of $66.03, for a total value of $521,306.85. The disclosure for this sale can be found here. Over the last three months, insiders sold 692,540 shares of company stock worth $45,359,357. Insiders own 53.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “First Trust Advisors LP Reduces Holdings in USANA Health Sciences, Inc. (USNA)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another publication, it was stolen and republished in violation of United States & international copyright and trademark laws. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2017/12/14/first-trust-advisors-lp-reduces-stake-in-usana-health-sciences-inc-usna.html.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply